GL1X · GenesisL1 explorer

Research workbench

Crystal structure of multidrug resistant HIV-1 protease clinical isolate PR20 in complex with saquinavir

Analyse Crystal structure of multidrug resistant HIV-1 protease clinical isolate PR20… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3UFN
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
UniProt
P03367
Ligands
ROC, CL
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 proteaseprotein997% helix, 53% strandP03367

Ligands and binding sites

  • ROC · (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14030.710.8236ROC, CL

Interfaces

1 interface between chains.

  • A–B · 1843 Ų buried · 35 hydrogen bonds · protein-protein

Compared structures

  • 3UFN · Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.